Strategic Advocates’s 21Shares XRP ETF TOXR Stock Holding History

Strategic Advocates’s Portfolio TOXR Stock Details TOXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-750	Closed	-$13.7K	–	654
2025 Q4	$13.7K	Buy	+750	New	+$13.8K	﹤0.01%	338

Other funds holding TOXR

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Strategic Advocates's TOXR Position: Q1 2026 in Review

Strategic Advocates sold out of 21Shares XRP ETF (TOXR) in Q1 2026, closing a stake of 750 shares — an estimated $13.7K sold.

Strategic Advocates first reported a position in TOXR in Q4 2025 and held it in 1 quarter. The position peaked at $13.7K in Q4 2025. 4 funds tracked by Wall St. Rank hold TOXR as of Q1 2026.

Strategic Advocates reported no remaining 21Shares XRP ETF position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 750 21Shares XRP ETF shares in Q1 2026, an estimated $13.7K.
Strategic Advocates first reported a position in 21Shares XRP ETF in Q4 2025 and held it in 1 quarter.
Strategic Advocates's 21Shares XRP ETF position peaked at $13.7K in Q4 2025.
4 funds tracked by Wall St. Rank held 21Shares XRP ETF as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.